Camelidae and Cervidae Brucellosis Study Guide

Overview and Clinical Importance

Brucellosis is a highly contagious zoonotic bacterial disease caused by various species of the genus Brucella. This disease has significant economic impact on livestock production worldwide and poses serious public health concerns. In camelids and cervids, brucellosis primarily manifests as reproductive failure, including abortion, stillbirth, and infertility.

Brucellosis is listed by the World Organisation for Animal Health (WOAH) and is a reportable disease in most countries. Understanding this disease is essential for NAVLE success, particularly regarding its zoonotic potential, diagnostic approaches, and control measures in wildlife reservoir populations.

Etiology and Brucella Species

Brucella organisms are small (0.5-0.7 by 0.6-1.5 micrometers), Gram-negative, non-motile, non-spore-forming, facultative intracellular coccobacilli. They are aerobic but may require supplemental CO2 for primary isolation. The organisms lack classical virulence factors such as exotoxins, capsules, fimbriae, or plasmids but possess unique mechanisms for intracellular survival.

Brucella Species and Host Specificity

Pathogenesis and Intracellular Survival

Brucella organisms are facultative intracellular pathogens with a unique ability to survive and replicate within host macrophages. Understanding this pathogenesis is crucial for comprehending disease persistence and treatment challenges.

Routes of Infection

• Ingestion: Most common route; organisms penetrate oral, nasal, or pharyngeal mucosa. Animals ingest contaminated fetal membranes, fluids, or milk.
• Inhalation: Aerosolized bacteria can enter through respiratory tract; significant occupational hazard.
• Conjunctival: Direct contact with contaminated fluids to eyes.
• Percutaneous: Through skin abrasions or wounds; venereal transmission possible but less common.
• In utero: Transplacental infection of fetuses from infected dams.

Intracellular Survival Mechanisms

After entry, Brucella organisms are rapidly phagocytosed by polymorphonuclear leukocytes and macrophages. However, they possess several mechanisms to avoid intracellular killing:

• Brucella-Containing Vacuole (BCV): The bacteria redirect their phagosome trafficking to avoid lysosomal fusion, creating a replicative niche associated with the endoplasmic reticulum.
• VirB Type IV Secretion System: This major virulence factor delivers effector proteins that modulate host cell functions and enable intracellular replication.
• Lipopolysaccharide (LPS): Smooth LPS (O-antigen) provides resistance to antimicrobial peptides and complement-mediated killing.
• Oxidative Stress Resistance: Superoxide dismutase (SOD) and catalase neutralize reactive oxygen intermediates produced by phagocytes.

Tissue Tropism and Reproductive Pathology

Brucella demonstrates marked tropism for the reproductive tract due to the presence of erythritol in placental and fetal tissues. The chorioallantoic trophoblasts are particularly susceptible, leading to massive bacterial replication, placentitis, and subsequent abortion.

In males: Organisms localize in the testes, epididymis, and accessory sex glands, causing orchitis, epididymitis, and potential infertility. Bacteria may be shed intermittently in semen.

In females: Following bacteremia, organisms colonize the gravid uterus, supramammary lymph nodes, and mammary gland. Bacteria are shed in milk, vaginal discharges, and products of abortion.

Clinical Signs by Species

Camelids (Llamas, Alpacas, and Camels)

Camelids are susceptible to both B. abortus and B. melitensis, with the latter being more commonly reported. Clinical manifestations in camelids are similar to those in bovines and small ruminants, although the naturally occurring incidence is relatively low.

Female Reproductive Signs

• Abortion (typically late gestation, especially affecting first pregnancy in camels)
• Stillbirth and birth of weak crias/calves
• Retained placenta (uncommon in camels compared to cattle)
• Fetal death and mummification
• Reduced milk yield
• Metritis and endometritis

Male Reproductive Signs

• Orchitis (testicular swelling, warmth, and pain)
• Epididymitis (particularly common in camels in endemic areas)
• Scrotal enlargement with hydrocele or pyocele on ultrasonography
• Testicular abscessation in severe cases
• Reduced libido and infertility

Non-Reproductive Signs

• Progressive loss of condition
• Arthritis and lameness (particularly carpal bursitis in reindeer)
• Lymphadenopathy (enlarged supramammary and genital lymph nodes)
• Many infected animals remain subclinically affected

Cervids (Elk, Deer, Bison, Reindeer, Caribou, and Moose)

Cervids are primarily affected by B. abortus, with caribou and reindeer also susceptible to B. suis (biovar 4). Free-ranging elk and bison in the Greater Yellowstone Area represent the last remaining reservoir of B. abortus in the United States.

Clinical Manifestations by Cervid Species

Diagnostic Approaches

Definitive diagnosis of brucellosis requires laboratory confirmation, as clinical signs are not pathognomonic. Diagnosis relies on a combination of serology for screening and bacterial culture or PCR for confirmation.

Serological Testing

Serological tests detect antibodies against Brucella lipopolysaccharide (LPS) O-antigen. Tests developed for cattle using B. abortus antigens are generally adequate for detecting B. melitensis and B. suis infections due to cross-reactivity among smooth Brucella species.

Bacterial Culture and Identification

Gold standard for definitive diagnosis. Culture is time-consuming (2-3 days for visible colonies) and requires biosafety precautions (BSL-3 recommended for virulent strains).

Appropriate Samples for Culture

• Aborted fetus (stomach contents, spleen, lung)
• Placenta and fetal membranes
• Vaginal swabs and discharges
• Milk and colostrum
• Semen and testicular/epididymal tissue
• Lymph nodes (supramammary, retropharyngeal, iliac)
• Hygroma fluid and joint aspirates

Molecular Diagnostics (PCR)

Polymerase chain reaction (PCR) assays provide rapid, sensitive detection of Brucella DNA. Species-specific primers and real-time PCR (targeting IS711 insertion sequence) allow identification without culture. PCR is particularly useful for confirmation of seropositive cases and typing of isolates.

Treatment Considerations

Treatment of brucellosis in animals is generally NOT recommended for the following reasons:

• Intracellular location of bacteria limits antibiotic efficacy
• Treatment does not reliably eliminate infection - animals remain chronic carriers
• Treated animals continue to shed bacteria intermittently
• Zoonotic risk persists despite clinical improvement
• Control programs require test-and-slaughter approach for eradication

For wildlife and valuable breeding animals where euthanasia is not feasible, prolonged antibiotic therapy with combination regimens (similar to human protocols) may be considered. This typically involves 6+ weeks of doxycycline combined with streptomycin or gentamicin, though cure rates are unreliable.

Prevention and Control Strategies

Vaccination

Vaccination is a key component of brucellosis control programs, although currently available vaccines have limitations in camelids and cervids.

Control Program Components

• Test and Slaughter: Identification and removal of seropositive animals; foundation of eradication programs
• Movement Control: Testing requirements before interstate/international transport; quarantine of positive herds
• Herd Certification: Certified Brucellosis-Free Herd Programs for cervids and camelids
• Wildlife Management: Reducing wildlife-livestock contact; managing supplemental feeding grounds; spatial/temporal separation
• Biosecurity: Proper disposal of aborted material; sanitation of premises; isolation of new additions

Zoonotic Considerations

Brucellosis is one of the most important zoonotic diseases worldwide. In humans, it causes undulant fever (Malta fever) with significant morbidity if untreated. Approximately 500,000 human cases occur globally each year.

Occupational Risk Groups

• Veterinarians and veterinary technicians
• Livestock farmers and ranchers
• Slaughterhouse and meat processing workers
• Hunters (particularly of elk, bison, feral swine, caribou)
• Wildlife biologists and researchers
• Laboratory personnel (most commonly reported laboratory-acquired bacterial infection)

Human Clinical Manifestations

Acute phase: Undulating fever, profuse sweating (sometimes with musty odor), chills, headache, myalgia, arthralgia, malaise, fatigue, anorexia, weight loss. Incubation period typically 2-4 weeks but can extend to months.

Chronic/Focal complications: Osteoarticular disease (sacroiliitis, spondylitis), epididymo-orchitis, endocarditis (main cause of death), neurobrucellosis, hepatosplenomegaly.

Prevention of Human Infection

• Personal protective equipment (gloves, goggles, N95 respirator, gowns) when handling potentially infected animals or tissues
• Avoid consumption of unpasteurized milk and dairy products
• Cook meat thoroughly (internal temperature 160 degrees F or higher) - freezing, smoking, and pickling do NOT kill Brucella
• Proper restraint during vaccination to prevent needle sticks or conjunctival exposure
• Safe field dressing techniques for hunters; wear gloves and eye protection
• Do not feed dogs raw meat or offal from potentially infected game

Memory Aids and Clinical Pearls

Species-Host Mnemonic: "ABM-SOM"

Abortus = Bovines/Bison (and elk)

Melitensis = Small ruminants (sheep/goats) and camelids

Suis = Swine and caribou/reindeer

Ovis = Ovine males (rams)

Melitensis is Most pathogenic to humans

Yellowstone Wildlife Fact: "50-70-RB"

50% = Approximate seroprevalence in Yellowstone bison

70% = Approximate efficacy of RB51 vaccine in cattle

RB51 = Rough mutant vaccine that does NOT work well in elk

Diagnostic Testing Mnemonic: "RBT to CFT to Culture"

Rapid Bengal Test = Screen (sensitive)

Complement Fixation Test = Confirm (specific)

Culture = Definitive diagnosis (gold standard)